Canopy growth corp CGC.US Overview Analysis
CGC AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.
CGC Current Performance
-27.34%
Canopy growth corp
-1.96%
Avg of Sector
-0.95%
S&P500
Top 10 High Relevance to CGC
Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
---|---|---|---|---|---|---|---|
ACB | Aurora cannabis inc | 3 | 4 | 2 | - | 1 | |
XTLB | Xtl biopharmaceuticals limited | 3 | 2 | 2 | - | 1 | |
CRON | Cronos group inc | 4 | 2 | 3 | - | 1 | |
TLRY | Tilray brands inc | 3 | 1 | 2 | 1 | 1 | |
OGI | Organigram holdings inc | 3 | 2 | 2 | - | 1 |
- ACB Aurora cannabis incValue 3Trend 4Swing Trading 2Whale Interest -Dividend 1See more
CGC Profile
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.